1. Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin. (18th May 2015) Authors: Szegedi, K.; Lutter, R.; Res, P.C.; Bos, J.D.; Luiten, R.M.; Kezic, S.; Middelkamp‐Hup, M.A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 11(2015:Nov.) Page Start: 2136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. (21st December 2012) Authors: Teulings, H.E.; Overkamp, M.; Ceylan, E.; Nieuweboer‐Krobotova, L.; Bos, J.D.; Nijsten, T.; Wolkerstorfer, A.W.; Luiten, R.M.; van der Veen, J.P.W. Journal: British journal of dermatology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients. (5th February 2020) Authors: Roekevisch, E.; Szegedi, K.; Hack, D.P.; Schram, M.E.; Res, P.C.J.M.; Bos, J.D.; Leeflang, M.M.G.; Luiten, R.M.; Kezic, S.; Spuls, P.I.; Middelkamp‐Hup, M.A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 7(2020) Page Start: 1545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Melanocyte antigen‐specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo. (10th March 2012) Authors: Kroon, M.W.; Kemp, E. Helen; Wind, B.S.; Krebbers, G.; Bos, J.D.; Gawkrodger, D.J.; Wolkerstorfer, A.; van der Veen, J.P. Wietze; Luiten, R.M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 27:Number 9(2013:Sep.) Page Start: 1172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years. (1st October 2016) Authors: Teulings, H.E.; Ceylan, E.; Overkamp, M.; Vrijman, C.; Bos, J.D.; Nijsten, T.E.; Wolkerstorfer, A.; Luiten, R.M.; van der Veen, J.P.W. Journal: British journal of dermatology Issue: Volume 175:Number 4(2016) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years. (3rd August 2016) Authors: Teulings, H.E.; Ceylan, E.; Overkamp, M.; Vrijman, C.; Bos, J.D.; Nijsten, T.E.; Wolkerstorfer, A.; Luiten, R.M.; van der Veen, J.P.W. Journal: British journal of dermatology Issue: Volume 175:Number 4(2016) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patients with atopic dermatitis with filaggrin loss‐of‐function mutations show good but lower responses to immunosuppressive treatment. (1st December 2017) Authors: Roekevisch, E.; Leeflang, M.M.G.; Schram, M.E.; Campbell, L.E.; Irwin McLean, W.H.; Kezic, S.; Bos, J.D.; Spuls, P.I.; Middelkamp‐Hup, M.A. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patients with atopic dermatitis with filaggrin loss‐of‐function mutations show good but lower responses to immunosuppressive treatment. (6th November 2017) Authors: Roekevisch, E.; Leeflang, M.M.G.; Schram, M.E.; Campbell, L.E.; Irwin McLean, W.H.; Kezic, S.; Bos, J.D.; Spuls, P.I.; Middelkamp‐Hup, M.A. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Provoking factors, including chemicals, in Dutch patients with vitiligo. (25th April 2013) Authors: Vrijman, C.; Hosseinpour, D.; Bakker, J.G.; Wolkerstorfer, A.; Bos, J.D.; van der Veen, J.P.W.; Luiten, R.M. Journal: British journal of dermatology Issue: Volume 168:Number 5(2013:May) Page Start: 1003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗